Brett King MD
Company: Yale University School of Medicine
Job title: Associate Professor, Dermatology
Seminars:
Balancing Benefit/Risk in the Dermatology Disease Space 11:15 am
day: Day Two
PANEL DISCUSSION: The JAK Class Black Box Warning: The Implications for the JAK Inhibitor Drug Development Landscape for Dermatology & Beyond 10:00 am
day: Day Two
Balancing Benefit/Risk in the Dermatology Disease Space 11:15 am
Considering whether the black box warning will stifle innovation across the JAK inhibitor class Correlating disease severity and quality of life with off-target effects of JAK inhibitors Rethinking how we define the black box warning to patientsRead more
day: Day Two
PANEL DISCUSSION: The JAK Class Black Box Warning: The Implications for the JAK Inhibitor Drug Development Landscape for Dermatology & Beyond 10:00 am
Cataloguing the implications across numerous disciplines the FDA issued JAK black box warning will have just as pharma was beginning to realise the potential the JAK/STAT pathway holds. Evaluating where the community sees the market potential for JAK inhibitors within the pharmaceutical industry despite the warning. Discussing ways in which companies may begin marketing their…Read more
day: Day Two